-
Publication Venue For
-
Coronary Volume to Left Ventricular Mass Ratio in Patients With Hypertension.
2023
-
In-hospital Outcomes of Patients With and Without Previous Coronary Artery Bypass Graft Surgery Who Present With a Non-ST-Segment Elevation Myocardial Infarction..
194:78-85.
2023
-
Trends and Outcomes in Cardiac Arrest Among Heart Failure Admissions..
194:93-101.
2023
-
Congenital Pulmonic Valve Dysfunction Treated With SAPIEN 3 Transcatheter Heart Valve (from the COMPASSION S3 Trial)..
190:102-109.
2023
-
Bending the Cardiovascular Event Curve by Evaluating the Potential Impact of Achieving Low-Density Lipoprotein Cholesterol Goal Across a Large Health System Among Secondary Prevention Patients..
186:91-99.
2023
-
Characteristics and Outcomes of Suspected Digoxin Toxicity and Immune Fab Treatment Over the Past Two Decades-2000-2020..
183:129-136.
2022
-
Effect of Novel Programming on Inappropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Very Low Ejection Fraction (from A MADIT-RIT)..
182:32-39.
2022
-
Outcomes After Acute Coronary Syndrome in Patients With Diabetes Mellitus and Peripheral Artery Disease (from the TRACER, TRILOGY-ACS, APPRAISE-2, and PLATO Clinical Trials)..
178:11-17.
2022
-
Utility of Cardiac Magnetic Resonance Imaging in Predicting Atrial Arrhythmias in Repaired Tetralogy of Fallot..
174:151-157.
2022
-
Hemodynamic and Clinical Determinants of Left Atrial Enlargement in Liver Transplant Candidates..
172:121-129.
2022
-
In-Hospital Outcomes in Pregnancy After Heart Transplantation..
172:68-72.
2022
-
Meta-Analysis of Nonalcoholic Fatty Liver Disease and Incident Heart Failure..
171:180-181.
2022
-
Epidemiology and Outcomes of Patients Readmitted to the Intensive Care Unit After Cardiac Intensive Care Unit Admission..
170:138-146.
2022
-
Low Blood Pressure Threshold for Adverse Outcomes During Left Ventricular Assist Device Support..
169:78-85.
2022
-
Relation of Norwood Shunt Type and Frequency of Arrhythmias at 6 Years (from the Single Ventricle Reconstruction Trial)..
169:107-112.
2022
-
Risk for Proteinuria in Newly Defined Hypertensive People Based on the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline..
168:83-89.
2022
-
Trends in Characteristics and Outcomes of Peripartum Cardiomyopathy Hospitalizations in the United States Between 2004 and 2018..
168:142-150.
2022
-
Global Longitudinal Strain to Predict Respiratory Failure and Death in Patients Admitted for COVID-19-Related Disease..
165:109-115.
2022
-
Relation of Cannabis Use to Elevated Atherosclerotic Cardiovascular Disease Risk Score..
165:46-50.
2022
-
Demographic and Regional Trends of Mortality in Patients With Acute Myocardial Infarction in the United States, 1999 to 2019..
164:7-13.
2022
-
Noninvasive Risk Score to Screen for Pulmonary Hypertension With Elevated Pulmonary Vascular Resistance in Diseases of Chronic Volume Overload..
159:113-120.
2021
-
Readmissions in Patients With Heart Failure and Mental Health Disorders (from a National Database)..
159:142-143.
2021
-
Clinical and Echocardiographic Characteristics of Patients Hospitalized With Acute Versus Chronic Heart Failure With Preserved Ejection Fraction (From the ARIC Study)..
158:59-65.
2021
-
Relation of the Metabolic Syndrome to Incident Colorectal Cancer in Young Adults Aged 20 to 49 Years..
158:132-138.
2021
-
Utility of High-Sensitivity Troponin Among Stable Patients With Chest Pain Undergoing Stress Imaging (from PROMISE)..
158:148-149.
2021
-
Contemporary Burden of Primary Versus Secondary Heart Failure Hospitalizations in the United States..
156:140-142.
2021
-
Impact of High Body Mass Index on Vascular and Bleeding Complications After Transcatheter Aortic Valve Implantation..
155:86-95.
2021
-
Sex-Differences in Cause of Death for Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction (from the ASCEND-HF Trial)..
154:123-126.
2021
-
Lipoprotein(a) Testing Patterns in a Large Health System..
153:43-50.
2021
-
Relation of Serum Uric Acid and Cardiovascular Events in Young Adults Aged 20-49 Years..
152:150-157.
2021
-
Cannabis Use and Electrocardiographic Myocardial Injury..
151:100-104.
2021
-
Impact of Contrast Echocardiography on Outcomes in Critically Ill Patients..
150:117-122.
2021
-
Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease..
148:69-77.
2021
-
Meta-Analysis of Efficacy of Sacubitril/Valsartan in Heart Failure With Preserved Ejection Fraction..
145:165-168.
2021
-
Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization..
138:26-32.
2021
-
Predicting the Development of Reduced Left Ventricular Ejection Fraction in Patients With Left Bundle Branch Block..
137:39-44.
2020
-
Relation of Low Normal Left Ventricular Ejection Fraction to Heart Failure Hospitalization in Blacks (From the Jackson Heart Study)..
136:100-106.
2020
-
Comparison of Mortality and Readmission in Non-Ischemic Versus Ischemic Cardiomyopathy After Implantable Cardioverter-Defibrillator Implantation..
133:116-125.
2020
-
Meta-Analysis of the Usefulness of Therapeutic Hypothermia After Cardiac Arrest..
133:48-53.
2020
-
Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial)..
132:36-43.
2020
-
Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF)..
132:66-71.
2020
-
A Meta-analysis of the Relationship Between Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19..
130:159-161.
2020
-
Association of P-Wave Axis With Incident Atrial Fibrillation in Diabetes Mellitus (from the ACCORD Trial)..
128:191-195.
2020
-
New Equations for Predicting Maximum Oxygen Uptake in Patients With Heart Failure..
128:7-11.
2020
-
Comparison of Characteristics and Outcomes of Patients With Heart Failure With Preserved Ejection Fraction With Versus Without Hyperuricemia or Gout..
127:64-72.
2020
-
Usefulness of Interleukin-1 Receptor Antagonists in Patients With Recurrent Pericarditis..
127:184-190.
2020
-
Lipoprotein (a): An Update on a Marker of Residual Risk and Associated Clinical Manifestations..
126:94-102.
2020
-
Trends in Treatment for Patients Hospitalized with Heart Failure with Preserved Ejection Fraction Before and After Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT)..
125:1655-1660.
2020
-
Meta-Analysis of Intraocular Bleeding With Dual Antiplatelet Therapy Using P2Y12 Inhibitors Prasugrel or Ticagrelor..
125:1280-1283.
2020
-
Strict Versus Lenient Versus Poor Rate Control Among Patients With Atrial Fibrillation and Heart Failure (from the Get With The Guidelines - Heart Failure Program)..
125:894-900.
2020
-
Usefulness of Noninvasively Measured Pulse Amplitude Changes During the Valsalva Maneuver to Identify Hospitalized Heart Failure Patients at Risk of 30-Day Heart Failure Events (from the PRESSURE-HF Study)..
125:916-923.
2020
-
Healthcare Resource Use and Expenditures in Patients Newly Diagnosed With Paroxysmal Supraventricular Tachycardia..
125:215-221.
2020
-
Comparison of Hydralazine/Nitrate and Angiotensin Receptor Neprilysin Inhibitor Use Among Black Versus Nonblack Americans With Heart Failure and Reduced Ejection Fraction (from CHAMP-HF)..
124:1900-1906.
2019
-
Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)..
124:1406-1412.
2019
-
Impact of Pulmonary Hypertension on Survival Following Device Closure of Atrial Septal Defects..
124:1460-1464.
2019
-
Echocardiographic Assessment of Right Ventricular Function and Response to Therapy in Pulmonary Arterial Hypertension..
124:1298-1304.
2019
-
A Cluster Analysis of the Japanese Multicenter Outpatient Registry of Patients With Atrial Fibrillation..
124:871-878.
2019
-
Global Longitudinal Strain and Immune Status in Patients Living With Human Immunodeficiency Virus..
124:966-971.
2019
-
Relation of Postdischarge Care Fragmentation and Outcomes in Transcatheter Aortic Valve Implantation from the STS/ACC TVT Registry..
124:912-919.
2019
-
Effects of Exercise Training With and Without Ranolazine on Peak Oxygen Consumption, Daily Physical Activity, and Quality of Life in Patients With Chronic Stable Angina Pectoris..
124:655-660.
2019
-
The Burden of Congestion in Patients Hospitalized With Acute Decompensated Heart Failure..
124:545-553.
2019
-
Blood Pressure Control and Cardiovascular Outcomes in Patients With Atrial Fibrillation (From the ORBIT-AF Registry)..
123:1628-1636.
2019
-
Physical Activity, Quality of Life, and Biomarkers in Atrial Fibrillation and Heart Failure With Preserved Ejection Fraction (from the NEAT-HFpEF Trial)..
123:1660-1666.
2019
-
Pursuit of the Optimal Antithrombotic Regimen for Patients With Non-ST-Segment Elevation Acute Coronary Syndrome Who Undergo Subsequent Percutaneous Coronary Intervention..
123:1736.
2019
-
Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris..
123:1399-1405.
2019
-
Outcomes Among Patients Transferred for Revascularization With Impella for Acute Myocardial Infarction With Cardiogenic Shock from the cVAD Registry..
123:1214-1219.
2019
-
Patient Phenotypes, Cardiovascular Risk, and Ezetimibe Treatment in Patients After Acute Coronary Syndromes (from IMPROVE-IT)..
123:1193-1201.
2019
-
Relation of Admission Blood Pressure to In-hospital and 90-Day Outcomes in Patients Presenting With Transient Ischemic Attack..
123:1083-1095.
2019
-
Size of Anterior Wall Acute Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention in United States Versus Europe/Australia Versus India (from the CRISP-AMI Randomized Controlled Trial)..
123:1026-1034.
2019
-
Patterns and Impact of Dual Antiplatelet Cessation on Cardiovascular Risk After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes..
123:709-716.
2019
-
Predictors and Changes in Cardiac Hemodynamics and Geometry With Transcatheter Aortic Valve Implantation..
123:813-819.
2019
-
Comparison of Outcomes and Frequency of Graft Failure With Use of Free Versus In Situ Internal Mammary Artery Bypass Conduits (from the PREVENT IV Trial)..
123:571-575.
2019
-
Glycated Hemoglobin and Outcomes of Heart Failure (from Get With the Guidelines-Heart Failure)..
123:618-626.
2019
-
Meta-Analysis of Effects of Digoxin on Survival in Patients with Atrial Fibrillation or Heart Failure: An Update..
123:69-74.
2019
-
Usefulness of Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Myocardial Infarction..
123:12-18.
2019
-
Dual Antiplatelet Therapy Cessation and Adverse Events After Drug-Eluting Stent Implantation in Patients at High Risk for Atherothrombosis (from the PARIS Registry)..
122:1638-1646.
2018
-
Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry)..
122:1677-1683.
2018
-
Clinical Characteristics, Procedural Factors, and Outcomes of Percutaneous Coronary Intervention in Patients With Mechanical and Bioprosthetic Heart Valves..
122:1536-1540.
2018
-
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status..
122:1451-1458.
2018
-
Relation of Volume Overload to Clinical Outcomes in Acute Heart Failure (From ASCEND-HF)..
122:1506-1512.
2018
-
Lack of Association Between Anemia and Intrinsic Left Ventricular Diastolic Function or Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction..
122:1359-1365.
2018
-
Outcomes of Patients Receiving Downstream Revascularization After Initial Medical Management for Non-ST-Segment Elevation Acute Coronary Syndromes (From the TRILOGY ACS Trial)..
122:1322-1329.
2018
-
Effect on Mortality of Higher Versus Lower β-Blocker (Metoprolol Succinate or Carvedilol) Dose in Patients With Heart Failure..
122:994-998.
2018
-
Renal Function and Exercise Training in AmbulatoryHeart Failure Patients With a Reduced Ejection Fraction..
122:999-1007.
2018
-
Clinical and Echocardiographic Predictors of Outcomes in Patients With Pulmonary Hypertension..
122:872-878.
2018
-
Effects of a 12-Week mHealth Program on FunctionalCapacity and Physical Activity in Patients With PeripheralArtery Disease..
122:879-884.
2018
-
Effect of Patent Foramen Ovale in Patients With Pulmonary Hypertension..
122:505-510.
2018
-
Post-Traumatic Stress Disorder and Heart Failure in Men Within the Veteran Affairs Health System..
122:275-278.
2018
-
Relation of Early Repolarization (J Point Elevation) to Mortality in Blacks (from the Jackson Heart Study)..
122:340-346.
2018
-
Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)..
122:255-260.
2018
-
Usefulness and Cost-Effectiveness of Universal Echocardiographic Contrast to Detect Left Ventricular Thrombus in Patients with Heart Failure and Reduced Ejection Fraction..
122:121-128.
2018
-
Sedentary Behavior and the Risk of Depression in Patients With Acute Coronary Syndromes..
121:1456-1460.
2018
-
Impact of Balloon Predilatation on Hemodynamics and Outcomes After Transcatheter Aortic Valve Implantation With the Self-Expanding CoreValve Prosthesis..
121:1358-1364.
2018
-
Alcohol Consumption and Risk of Coronary Artery Disease (from the Million Veteran Program)..
121:1162-1168.
2018
-
Controversies and Challenges of Ventricular Assist Device Therapy..
121:1219-1224.
2018
-
Influence of Aortic Stiffness on Aortic-Root Growth Rate and Outcome in Patients With the Marfan Syndrome..
121:1094-1101.
2018
-
Relation of Age and Health-Related Quality of Life to Invasive Versus Ischemia-Guided Management of Patients with Non-ST Elevation Myocardial Infarction..
121:789-795.
2018
-
Effect of Age and Renal Function on Survival After Left Ventricular Assist Device Implantation..
120:2221-2225.
2017
-
Evaluation of Industrial Compensation to Cardiologists in 2015..
120:2294-2298.
2017
-
Comparison of Incidence of Left Ventricular Systolic Dysfunction Among Patients With Left Bundle Branch Block Versus Those With Normal QRS Duration..
120:1990-1997.
2017
-
Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)..
120:1837-1840.
2017
-
Usefulness of Coronary Artery Calcium to Predict Heart Failure With Preserved Ejection Fraction in Men Versus Women (from the Multi-Ethnic Study of Atherosclerosis)..
120:1847-1853.
2017
-
Utilization of Standard and Target-Specific Oral Anticoagulants Among Adults in the United Kingdom With Incident Atrial Fibrillation..
120:1820-1829.
2017
-
Usefulness of Myocardial Annular Velocity Change During Mental Stress to Predict Cardiovascular Outcome in Patients With Coronary Artery Disease (From the Responses of Mental Stress-Induced Myocardial Ischemia to Escitalopram Treatment Trial)..
120:1495-1500.
2017
-
Impact of Tachyarrhythmia Detection Rate and Time from Detection to Shock on Outcomes in Nationwide US Practice..
120:1325-1331.
2017
-
Usefulness of Pulse Amplitude Changes During the Valsalva Maneuver Measured Using Finger Photoplethysmography to Identify Elevated Pulmonary Capillary Wedge Pressure in Patients With Heart Failure..
120:966-972.
2017
-
Meta-analysis of Placebo-Controlled Randomized Controlled Trials on the Prevalence of Statin Intolerance..
120:774-781.
2017
-
Right-Sided Cardiac Dysfunction in Heart Failure With Preserved Ejection Fraction and Worsening Renal Function..
120:274-278.
2017
-
Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network)..
120:98-105.
2017
-
Implications of Alternative Hepatorenal Prognostic Scoring Systems in Acute Heart Failure (from DOSE-AHF and ROSE-AHF)..
119:2003-2009.
2017
-
Relation of Risk of Stroke in Patients With Atrial Fibrillation to Body Mass Index (from Patients Treated With Rivaroxaban and Warfarin in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation Trial)..
119:1989-1996.
2017
-
Comparison of Clinical Characteristics and Outcomes of Patients With Versus Without Diabetes Mellitus and With Versus Without Angina Pectoris (from the Duke Databank for Cardiovascular Disease)..
119:1703-1709.
2017
-
Effect of Atrial Fibrillation on Mortality, Stroke Risk, and Quality-of-Life Scores in Patients With Heart Failure (from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF])..
119:1763-1769.
2017
-
Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials)..
119:1710-1716.
2017
-
Management of Major Bleeding in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants Compared With Warfarin in Clinical Practice (from Phase II of the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation [ORBIT-AF II])..
119:1590-1595.
2017
-
Comparative Efficacy of Coronary Revascularization Procedures for Multivessel Coronary Artery Disease in Patients With Chronic Kidney Disease..
119:1344-1351.
2017
-
Use of Antiarrhythmic Medications in Medicare Part D Patients With an Implantable Cardioverter-Defibrillator and Ventricular Tachycardia..
119:1401-1406.
2017
-
Comparison of Delay Times from Symptom Onset to Medical Contact in Blacks Versus Whites With Acute Myocardial Infarction..
119:1127-1134.
2017
-
Incidence and Predictors of Left Atrial Appendage Thrombus in Patients Treated With Nonvitamin K Oral Anticoagulants Versus Warfarin Before Catheter Ablation for Atrial Fibrillation..
119:1017-1022.
2017
-
Usefulness of a Noninvasive Device to Identify Elevated Left Ventricular Filling Pressure Using Finger Photoplethysmography During a Valsalva Maneuver..
119:1053-1060.
2017
-
Effect of Early Initiation of Mechanical Circulatory Support on Survival in Cardiogenic Shock..
119:845-851.
2017
-
Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function..
119:886-892.
2017
-
Comparison of the Incidence of Major Bleeding With Rivaroxaban Use Among Nonvalvular Atrial Fibrillation Patients With Versus Without Diabetes Mellitus..
119:753-759.
2017
-
Implications of the LEGACY trial on US Atrial Fibrillation Patients: An NCDR Research to Practice (R2P) Project..
119:579-584.
2017
-
Usefulness of Icosapent Ethyl (Eicosapentaenoic Acid Ethyl Ester) in Women to Lower Triglyceride Levels (Results from the MARINE and ANCHOR Trials)..
119:397-403.
2017
-
Serum Potassium Levels and Outcome in Acute Heart Failure (Data from the PROTECT and COACH Trials)..
119:290-296.
2017
-
Implications of Serum Chloride Homeostasis in Acute Heart Failure (from ROSE-AHF)..
119:78-83.
2017
-
Antiplatelet Effect Durability of a Novel, 24-Hour, Extended-Release Prescription Formulation of Acetylsalicylic Acid in Patients With Type 2 Diabetes Mellitus..
118:1941-1947.
2016
-
Gender Differences in Associations Between Intraprocedural Thrombotic Events During Percutaneous Coronary Intervention and Adverse Outcomes..
118:1661-1668.
2016
-
Relation of Post-Coronary Artery Bypass Graft Creatine Kinase-MB Elevations and New Q Waves With Long-Term Cardiovascular Death in Patients With Diabetes Mellitus and Multivessel Coronary Artery Disease..
118:1655-1660.
2016
-
Effect of Release of the First Pediatric Appropriate Use Criteria on Transthoracic Echocardiogram Ordering Practice..
118:1545-1551.
2016
-
Relation of Angina Pectoris to Outcomes, Quality of Life, and Response to Exercise Training in Patients With Chronic Heart Failure (from HF-ACTION)..
118:1211-1216.
2016
-
Trends in Bare-Metal Stent Use in the United States in Patients Aged ≥65 Years (from the CathPCI Registry)..
118:959-966.
2016
-
Impact of Stress Cardiac Magnetic Resonance Imaging on Clinical Care..
118:924-929.
2016
-
Oxidized Low-Density Lipoprotein-β2-Glycoprotein I Complex But Not Free Oxidized LDL Is Associated With the Presence and Severity of Coronary Artery Disease..
118:673-678.
2016
-
Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices..
118:733-738.
2016
-
Frequency of Disparities in Laboratory Testing After Statin Initiation in Subjects ≥65 Years..
118:376-382.
2016
-
Relation of Baseline Renal Dysfunction With Outcomes in Patients Undergoing Popliteal and Infrapopliteal Percutaneous Peripheral Arterial Interventions..
118:298-302.
2016
-
Comparison of Frequency of Frailty and Severely Impaired Physical Function in Patients ≥60 Years Hospitalized With Acute Decompensated Heart Failure Versus Chronic Stable Heart Failure With Reduced and Preserved Left Ventricular Ejection Fraction..
117:1953-1958.
2016
-
Impact of Anemia on Platelet Reactivity and Ischemic and Bleeding Risk: From the Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents Study..
117:1877-1883.
2016
-
Geographic Differences in Patients in a Global Acute Heart Failure Clinical Trial (from the ASCEND-HF Trial)..
117:1771-1778.
2016
-
Should Physicians be Encouraged to use Generic Names and to Prescribe Generic Drugs?.
117:1851-1852.
2016
-
Assessment of Device-Related Thrombus and Associated Clinical Outcomes With the WATCHMAN Left Atrial Appendage Closure Device for Embolic Protection in Patients With Atrial Fibrillation (from the PROTECT-AF Trial)..
117:1127-1134.
2016
-
Serum Osmolality and Postdischarge Outcomes After Hospitalization for Heart Failure..
117:1144-1150.
2016
-
Relation of Elevated Heart Rate in Patients With Heart Failure With Reduced Ejection Fraction to One-Year Outcomes and Costs..
117:946-951.
2016
-
Usefulness of Low Cardiac Index to Predict Sleep-Disordered Breathing in Chronic Thromboembolic Pulmonary Hypertension..
117:1001-1005.
2016
-
Conflicts of Interest and Outcomes of Cardiovascular Trials..
117:858-860.
2016
-
Relation of Activated Clotting Times During Percutaneous Coronary Intervention to Outcomes..
117:703-708.
2016
-
Temporal Changes in Postdischarge Mortality Risk After Hospitalization for Heart Failure (from the EVEREST Trial)..
117:611-616.
2016
-
Effects of Polyunsaturated Fatty Acid Treatment on Postdischarge Outcomes After Acute Myocardial Infarction..
117:340-346.
2016
-
Torsemide Versus Furosemide in Patients With Acute Heart Failure (from the ASCEND-HF Trial)..
117:404-411.
2016
-
Usefulness of Intra-aortic Balloon Pump Counterpulsation..
117:469-476.
2016
-
Impact of Funding Source on Clinical Trial Results Including Cardiovascular Outcome Trials..
116:1944-1947.
2015
-
Outcomes and worsening renal function in patients hospitalized with heart failure with preserved ejection fraction..
116:1534-1540.
2015
-
Effect of Falls on Frequency of Atrial Fibrillation and Mortality Risk (from the REasons for Geographic And Racial Differences in Stroke Study)..
116:1213-1218.
2015
-
Using Natriuretic Peptides for Selection of Patients in Acute Heart Failure Clinical Trials..
116:1304-1310.
2015
-
Comparison of 2-Year Outcomes of Extended Criteria Cardiac Transplantation Versus Destination Left Ventricular Assist Device Therapy Using Continuous Flow..
116:573-579.
2015
-
Contemporary cardiovascular device clinical trials (trends and patterns 2001 to 2012)..
116:307-312.
2015
-
Frequency and Effects of Excess Dosing of Anticoagulants in Patients ≤55 Years With Acute Myocardial Infarction Who Underwent Percutaneous Coronary Intervention (from the VIRGO Study)..
116:1-7.
2015
-
Statin Treatment by Low-Density Lipoprotein Cholesterol Levels in Patients With Non-ST-Segment Elevation Myocardial Infarction/Unstable Angina Pectoris (from the CRUSADE Registry)..
115:1655-1660.
2015
-
Comparison of aortic annulus size by transesophageal echocardiography and computed tomography angiography with direct surgical measurement..
115:1568-1573.
2015
-
Evaluation of Cardiac Magnetic Resonance as a Surrogate in ST-Segment Elevation Myocardial Infarction..
115:1607-1614.
2015
-
Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial)..
115:1325-1332.
2015
-
Impact of exercise stress testing on diagnostic gene expression in patients with obstructive and nonobstructive coronary artery disease..
115:1346-1350.
2015
-
Outcomes after nonemergent electrical cardioversion for atrial arrhythmias..
115:1407-1414.
2015
-
Prognostic value of serial B-type natriuretic peptide measurement in transcatheter aortic valve replacement (from the PARTNER Trial)..
115:1265-1272.
2015
-
Relation of fish oil supplementation to markers of atherothrombotic risk in patients with cardiovascular disease not receiving lipid-lowering therapy..
115:1204-1211.
2015
-
Exercise heart rates in patients with hypertrophic cardiomyopathy..
115:1144-1150.
2015
-
Meta-analysis of direct and indirect comparison of ticagrelor and prasugrel effects on platelet reactivity..
115:716-723.
2015
-
Usefulness of retinal microvascular endothelial dysfunction as a predictor of coronary artery disease..
115:609-613.
2015
-
Incidence and impact of totally occluded culprit coronary arteries in patients presenting with non-ST-segment elevation myocardial infarction..
115:428-433.
2015
-
Antiarrhythmic drug use in patients <65 years with atrial fibrillation and without structural heart disease..
115:316-322.
2015
-
Predictors and progression of aortic stenosis in patients with preserved left ventricular ejection fraction..
115:86-92.
2015
-
Relation of dyspnea severity on admission for acute heart failure with outcomes and costs..
115:75-81.
2015
-
Prognostic value of angiographic lesion complexity in patients with acute coronary syndromes undergoing percutaneous coronary intervention (from the acute catheterization and urgent intervention triage strategy trial)..
114:1638-1645.
2014
-
Relation of serum uric acid levels and outcomes among patients hospitalized for worsening heart failure with reduced ejection fraction (from the efficacy of vasopressin antagonism in heart failure outcome study with tolvaptan trial)..
114:1713-1721.
2014
-
Persistence of evidence-based medication use after discharge from academic versus nonacademic hospitals among patients with non-ST-segment elevation myocardial infarction..
114:1479-1484.
2014
-
Impact of diabetes mellitus on clinical characteristics, management, and in-hospital outcomes in patients with acute myocardial infarction (from the NCDR)..
114:1136-1144.
2014
-
Characteristics and outcomes of patients with heart failure and discordant findings by right-sided heart catheterization and cardiopulmonary exercise testing..
114:1059-1064.
2014
-
Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study)..
114:811-819.
2014
-
Comparison of safety of sotalol versus amiodarone in patients with atrial fibrillation and coronary artery disease..
114:716-722.
2014
-
Comparison of the use of hemodynamic support in patients ≥80 years versus patients <80 years during high-risk percutaneous coronary interventions (from the Multicenter PROTECT II Randomized Study)..
114:657-664.
2014
-
Mineralocorticoid receptor antagonist use in hospitalized patients with heart failure, reduced ejection fraction, and diabetes mellitus (from the EVEREST Trial)..
114:743-750.
2014
-
Usefulness and safety of vorapaxar in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention (from the TRACER Trial)..
114:665-673.
2014
-
Comparison of hybrid coronary revascularization versus coronary artery bypass grafting in patients≥65 years with multivessel coronary artery disease..
114:224-229.
2014
-
Comparison of long-term postoperative sequelae in patients with tetralogy of Fallot versus isolated pulmonic stenosis..
114:300-304.
2014
-
Cost analysis of periprocedural imaging in patients undergoing catheter ablation for atrial fibrillation..
114:266-271.
2014
-
Frequency of nonsystem delays in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention and implications for door-to-balloon time reporting (from the American Heart Association Mission: Lifeline program)..
114:24-28.
2014
-
Analysis of geographic variations in the diagnosis and treatment of patients with aortic stenosis in North Carolina..
113:1874-1878.
2014
-
Comparison of the relation between left ventricular anatomy and QRS duration in patients with cardiomyopathy with versus without left bundle branch block..
113:1717-1722.
2014
-
Angiographic outcomes with early eptifibatide therapy in non-ST-segment elevation acute coronary syndrome (from the EARLY ACS Trial)..
113:1297-1305.
2014
-
Characteristics and outcomes in patients undergoing percutaneous coronary intervention following cardiac arrest (from the NCDR)..
113:1087-1092.
2014
-
Association of aspirin dose and vorapaxar safety and efficacy in patients with non-ST-segment elevation acute coronary syndrome (from the TRACER Trial)..
113:936-944.
2014
-
Right ventricular morphology and systolic function in left ventricular noncompaction cardiomyopathy..
113:1018-1023.
2014
-
Characteristics, management, and outcomes of cocaine-positive patients with acute coronary syndrome (from the National Cardiovascular Data Registry)..
113:749-756.
2014
-
Predictors of reperfusion delay in patients with ST elevation myocardial infarction self-transported to the hospital (from the American Heart Association's Mission: Lifeline Program)..
113:798-802.
2014
-
Utility of the Penn classification in predicting outcomes of surgery for acute type a aortic dissection..
113:724-730.
2014
-
Incidence and survival of hospitalized acute decompensated heart failure in four US communities (from the Atherosclerosis Risk in Communities Study)..
113:504-510.
2014
-
Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial)..
113:222-228.
2014
-
Influence of presenting electrocardiographic findings on the treatment and outcomes of patients with non-ST-segment elevation myocardial infarction..
113:256-261.
2014
-
Left ventricular hypertrophy patterns and incidence of heart failure with preserved versus reduced ejection fraction..
113:117-122.
2014
-
Outcomes of a pharmacoinvasive strategy for successful versus failed fibrinolysis and primary percutaneous intervention in acute myocardial infarction (from the STrategic Reperfusion Early After Myocardial Infarction [STREAM] study)..
114:811-819.
2014
-
Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial)..
112:1812-1818.
2013
-
Relation of serum magnesium levels and postdischarge outcomes in patients hospitalized for heart failure (from the EVEREST Trial)..
112:1763-1769.
2013
-
Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure..
112:1625-1631.
2013
-
New-onset atrial fibrillation after acute myocardial infarction and its relation to admission biomarkers (from the TRIUMPH registry)..
112:1390-1395.
2013
-
Relation of admission high-density lipoprotein cholesterol level and in-hospital mortality in patients with acute non-ST segment elevation myocardial infarction (from the National Cardiovascular Data Registry)..
112:1057-1062.
2013
-
Comparative effectiveness of pharmacotherapies for prevention of atrial fibrillation following coronary artery bypass surgery..
112:954-960.
2013
-
Hemoglobin, exercise training, and health status in patients with chronic heart failure (from the HF-ACTION randomized controlled trial)..
112:971-976.
2013
-
Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI Trial)..
112:911-917.
2013
-
Applying antithrombotic therapies to improve outcomes in patients with atrial fibrillation..
112:S3.
2013
-
A novel risk classification paradigm for patients with impaired glucose tolerance and high cardiovascular risk..
112:231-237.
2013
-
Association between bilirubin and mode of death in severe systolic heart failure..
111:1192-1197.
2013
-
Characteristics and in-hospital outcomes of patients with non-ST-segment elevation myocardial infarction undergoing an invasive strategy according to hemoglobin levels..
111:1099-1103.
2013
-
Reply: To PMID 23245838..
111:1079.
2013
-
Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF)..
111:582-587.
2013
-
Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial)..
111:574-581.
2013
-
Temporal trends in medical therapies for ST- and non-ST elevation myocardial infarction: (from the Atherosclerosis Risk in Communities [ARIC] Surveillance Study)..
111:305-311.
2013
-
Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction..
111:178-184.
2013
-
Prehospitalization antiplatelet therapy and outcomes after saphenous vein graft intervention..
111:153-158.
2013
-
Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation..
111:219-224.
2013
-
Development of a method to risk stratify patients with heart failure for 30-day readmission using implantable device diagnostics..
111:79-84.
2013
-
Preoperative anxiety as a predictor of mortality and major morbidity in patients aged >70 years undergoing cardiac surgery..
111:137-142.
2013
-
Gender does not affect postdischarge outcomes in patients hospitalized for worsening heart failure with reduced ejection fraction (from the Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan [EVEREST] Trial)..
110:1803-1808.
2012
-
Prognostic value of monocyte count in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial)..
110:1657-1662.
2012
-
Relative prognostic value of baseline Q wave and time from symptom onset among men and women with ST-elevation myocardial infarction undergoing percutaneous coronary intervention..
110:1555-1560.
2012
-
Comparison of need for operative therapy in patients with mitral valve prolapse involving both leaflets versus posterior leaflet only..
110:1350-1353.
2012
-
Stress imaging use and repeat revascularization among medicare patients with high-risk coronary artery disease..
110:1270-1274.
2012
-
In-hospital resource use and medical costs in the last year of life by mode of death (from the HF-ACTION randomized controlled trial)..
110:1150-1155.
2012
-
Downstream testing and subsequent procedures after coronary computed tomographic angiography following coronary stenting in patients ≥65 years of age..
110:776-783.
2012
-
Effect of obesity on B-type natriuretic peptide levels in patients with pulmonary arterial hypertension..
110:909-914.
2012
-
Cardiologist concordance with the American College of Cardiology appropriate use criteria for cardiac testing in patients with coronary artery disease..
110:337-344.
2012
-
Impact of drug eluting stent length on outcomes of percutaneous coronary intervention (from the EVENT registry)..
110:350-355.
2012
-
Association of serum triiodothyronine with B-type natriuretic peptide and severe left ventricular diastolic dysfunction in heart failure with preserved ejection fraction..
110:234-239.
2012
-
Comparative value of coronary artery calcium and multiple blood biomarkers for prognostication of cardiovascular events..
109:1449-1453.
2012
-
Comparison of Clinical characteristics and long-term outcomes of patients with ischemic cardiomyopathy with versus without angina pectoris (from the Duke Databank for Cardiovascular Disease)..
109:1272-1277.
2012
-
Interchangeability of activated clotting time values across different point-of-care systems..
109:1379-1382.
2012
-
Red blood cell indices and development of hospital-acquired anemia during acute myocardial infarction..
109:1104-1110.
2012
-
Comparison of bleeding and in-hospital mortality in Asian-Americans versus Caucasian-Americans with ST-elevation myocardial infarction receiving reperfusion therapy..
109:925-931.
2012
-
Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial)..
109:805-812.
2012
-
Parental intermittent claudication as risk factor for claudication in adults..
109:736-741.
2012
-
Predicting costs among medicare beneficiaries with heart failure..
109:705-711.
2012
-
Comparison of clinical characteristics, treatments and outcomes of patients with ST-elevation acute myocardial infarction with versus without new or presumed new left bundle branch block (from NCDR®)..
109:497-501.
2012
-
Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysis..
109:320-326.
2012
-
Comparison of the frequency of coronary artery disease in alcohol-related versus non-alcohol-related endstage liver disease..
108:1552-1555.
2011
-
Pulmonary function in patients with acute coronary syndrome treated with ticagrelor or clopidogrel (from the Platelet Inhibition and Patient Outcomes [PLATO] pulmonary function substudy)..
108:1542-1546.
2011
-
Mode of death and hospitalization from the Second Follow-up Serial Infusions of Nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes..
108:1449-1457.
2011
-
Associations of patient demographic characteristics and regional physician density with early physician follow-up among medicare beneficiaries hospitalized with heart failure..
108:985-991.
2011
-
Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes..
108:949-954.
2011
-
Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise - STRRIDE-AT/RT)..
108:838-844.
2011
-
Diagnosing acute myocardial infarction in patients with left bundle branch block..
108:782-788.
2011
-
Risk stratification in the setting of non-ST elevation acute coronary syndromes 1999-2007..
108:617-624.
2011
-
Association of troponin T, detected with highly sensitive assay, and outcomes in infective endocarditis..
108:416-420.
2011
-
Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION)..
108:380-384.
2011
-
Effect of clopidogrel pretreatment on ischemic complications of percutaneous coronary intervention among bivalirudin-treated patients (from the EVENT registry)..
107:1751-1756.
2011
-
Patterns and predictors of evidence-based medication continuation among hospitalized heart failure patients (from Get With the Guidelines-Heart Failure)..
107:1818-1823.
2011
-
Effect of prior stroke on the use of evidence-based therapies and in-hospital outcomes in patients with myocardial infarction (from the NCDR ACTION GWTG registry)..
107:1441-1446.
2011
-
In-hospital major bleeding during ST-elevation and non-ST-elevation myocardial infarction care: derivation and validation of a model from the ACTION Registry®-GWTG™..
107:1136-1143.
2011
-
Quality of life in pediatric patients with implantable cardioverter defibrillators..
107:1023-1027.
2011
-
Identifying patients at risk for premature discontinuation of thienopyridine after coronary stent implantation..
107:685-689.
2011
-
Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study)..
107:545-551.
2011
-
The editor's roundtable: Closing the clinical practice gap-using evidence-based treatments for managing lipids..
107:230-242.
2011
-
patient and practice factors associated with improvement in use of guideline-recommended therapies for outpatients with heart failure (from the IMPROVE HF trial)..
107:250-258.
2011
-
Impact of recovery of renal function on long-term mortality after coronary artery bypass grafting..
106:1728-1734.
2010
-
Effect of amiodarone-induced hyperthyroidism on left ventricular outflow obstruction after septal myectomy for hypertrophic cardiomyopathy..
106:1670-1672.
2010
-
Relation of size of secondary ventricles to exercise performance in children after fontan operation..
106:1652-1656.
2010
-
United States stock market performance and acute myocardial infarction rates in 2008-2009 (from the Duke Databank for Cardiovascular Disease)..
106:1545-1549.
2010
-
Comparison of outcomes in patients aged <75, 75 to 84, and ≥ 85 years with ST-elevation myocardial infarction (from the ACTION Registry-GWTG)..
106:1382-1388.
2010
-
Antiplatelet therapy in acute coronary syndrome (ACS): applying new science to clinical decisions..
106:S2-S3.
2010
-
Relation of level of B-type natriuretic peptide with outcomes in patients with infective endocarditis..
106:1011-1015.
2010
-
Effect of coronary target lesion revascularization on late cardiac events after insertion of sirolimus-eluting or bare metal stents..
106:774-779.
2010
-
Usefulness of the QRS score as a strong prognostic marker in patients discharged after undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction..
106:630-634.
2010
-
Motorized scooters: boon or bane?.
106:601.
2010
-
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy)..
106:180-186.
2010
-
Continuous versus bolus dosing of Furosemide for patients hospitalized for heart failure..
105:1794-1797.
2010
-
Long-term outcomes of medicare beneficiaries with worsening renal function during hospitalization for heart failure..
105:1786-1793.
2010
-
Outpatient cardiology practices with advanced practice nurses and physician assistants provide similar delivery of recommended therapies (findings from IMPROVE HF)..
105:1773-1779.
2010
-
Incidence of caffeine in serum of patients undergoing dipyridamole myocardial perfusion stress test by an intensive versus routine caffeine history screening..
105:1474-1479.
2010
-
Cross-sectional relations of lipid concentrations to left ventricular structural attributes..
105:1297-1299.
2010
-
Meta-analysis of the effect of radiofrequency catheter ablation on left atrial size, volumes and function in patients with atrial fibrillation..
105:1317-1326.
2010
-
Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention..
105:1065-1069.
2010
-
Influence of renal function on the use of guideline-recommended therapies for patients with heart failure..
105:1140-1146.
2010
-
Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)..
105:667-671.
2010
-
Effect of motorized scooters on quality of life and cardiovascular risk..
105:672-676.
2010
-
N-terminal pro-brain natriuretic peptide and outcomes in patients undergoing surgical ventricular restoration..
105:640-644.
2010
-
Current use of aspirin and antithrombotic agents in the United States among outpatients with atherothrombotic disease (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)..
105:445-452.
2010
-
Long-term safety and efficacy of triple combination ezetimibe/simvastatin plus extended-release niacin in patients with hyperlipidemia..
105:487-494.
2010
-
Adherence to guideline-recommended adjunctive heart failure therapies among outpatient cardiology practices (findings from IMPROVE HF)..
105:255-260.
2010
-
Quality of care and in-hospital outcomes in patients with coronary heart disease in rural and urban hospitals (from Get With the Guidelines-Coronary Artery Disease Program)..
105:139-143.
2010
-
Impact of left ventricular ejection fraction on clinical outcomes over five years after infarct-related coronary artery recanalization (from the Occluded Artery Trial [OAT])..
105:10-16.
2010
-
Mechanical complications after percutaneous coronary intervention in ST-elevation myocardial infarction (from APEX-AMI)..
105:59-63.
2010
-
Prognosis after change in left ventricular ejection fraction during mental stress testing in patients with stable coronary artery disease..
105:25-28.
2010
-
Time-dependent risk of Fidelis lead failure..
105:95-99.
2010
-
Relation of 12-lead electrocardiogram patterns to implanted defibrillator-terminated ventricular tachyarrhythmias in hypertrophic cardiomyopathy..
104:1722-1726.
2009
-
Usefulness of the Duke Sudden Cardiac Death risk score for predicting sudden cardiac death in patients with angiographic (>75% narrowing) coronary artery disease..
104:1624-1630.
2009
-
Effects of combination lipid therapy on coronary stenosis progression and clinical cardiovascular events in coronary disease patients with metabolic syndrome: a combined analysis of the Familial Atherosclerosis Treatment Study (FATS), the HDL-Atherosclerosis Treatment Study (HATS), and the Armed Forces Regression Study (AFREGS)..
104:1457-1464.
2009
-
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY)..
104:1330-1335.
2009
-
Relation of patient age and mortality to reported contraindications to early beta-blocker use for non-ST-elevation acute coronary syndrome..
104:1324-1329.
2009
-
Six-month follow-up of patients with in-hospital thrombocytopenia during heparin-based anticoagulation (from the Complications After Thrombocytopenia Caused by Heparin [CATCH] registry)..
104:1285-1291.
2009
-
Persistent tricuspid regurgitation and its predictor in adults after percutaneous and isolated surgical closure of secundum atrial septal defect..
104:856-861.
2009
-
Antiplatelet therapy in older adults with non-ST-segment elevation acute coronary syndrome: considering risks and benefits..
104:16C-21C.
2009
-
Effectiveness and safety of carotid artery stenting for significant carotid stenosis in patients with contralateral occlusion (from the German ALKK-CAS Registry experience)..
104:725-731.
2009
-
Aspirin Resistance in healthy drug-naive men versus women (from the Heredity and Phenotype Intervention Heart Study)..
104:606-612.
2009
-
Prevalence of aspirin and clopidogrel resistance among patients with and without drug-eluting stent thrombosis..
104:525-530.
2009
-
Prevalence, predictors, and in-hospital outcomes of non-infarct artery intervention during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction (from the National Cardiovascular Data Registry)..
104:507-513.
2009
-
Comparison of echocardiographic and cardiac magnetic resonance imaging measurements of functional single ventricular volumes, mass, and ejection fraction (from the Pediatric Heart Network Fontan Cross-Sectional Study)..
104:419-428.
2009
-
Incidence and predictors of stroke associated with percutaneous coronary intervention..
104:349-353.
2009
-
Contribution of bleeding and thromboembolic events to in-hospital mortality among patients with thrombocytopenia treated with heparin..
104:292-297.
2009
-
Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome..
104:175-181.
2009
-
Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial)..
104:151-157.
2009
-
Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF)..
104:107-115.
2009
-
Relation of severe coronary artery narrowing to insulin or thiazolidinedione use in patients with type 2 diabetes mellitus (from the Bypass Angioplasty Revascularization Investigation 2 Diabetes Study)..
104:52-58.
2009
-
Effect of biventricular pacing during a ventricular sensed event..
103:1741-1745.
2009
-
Association between mortality and persistent use of beta blockers and angiotensin-converting enzyme inhibitors in patients with left ventricular systolic dysfunction and coronary artery disease..
103:1518-1524.
2009
-
Effect of long-term clopidogrel treatment on platelet function and inflammation in patients undergoing coronary arterial stenting..
103:1546-1550.
2009
-
Role of frailty in patients with cardiovascular disease..
103:1616-1621.
2009
-
Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial)..
103:1196-1203.
2009
-
Relation of depression to severity of illness in heart failure (from Heart Failure And a Controlled Trial Investigating Outcomes of Exercise Training [HF-ACTION])..
103:1285-1289.
2009
-
Door-to-balloon times in hospitals within the get-with-the-guidelines registry after initiation of the door-to-balloon (D2B) Alliance..
103:1051-1055.
2009
-
Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry)..
103:766-771.
2009
-
Advances in antiplatelet therapy: agents in clinical development..
103:40A-51A.
2009
-
Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes..
103:295-300.
2009
-
Impact of left ventricular dysfunction on hospital mortality among patients undergoing elective percutaneous coronary intervention..
103:355-360.
2009
-
Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study)..
103:181-186.
2009
-
ST resolution 1 hour after fibrinolysis for prediction of myocardial infarct size: insights from ASSENT 3..
103:154-158.
2009
-
Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE])..
103:175-180.
2009
-
Usefulness of hand-carried ultrasound to predict elevated left ventricular filling pressure..
103:246-247.
2009
-
Association of weight change with subsequent outcomes in patients hospitalized with acute decompensated heart failure..
103:76-81.
2009
-
Morphology of the patent foramen ovale in asymptomatic versus symptomatic (stroke or transient ischemic attack) patients..
103:124-129.
2009
-
Relation of corneal arcus to cardiovascular disease (from the Framingham Heart Study data set)..
103:64-66.
2009
-
Influence of hospital length of stay for heart failure on quality of care..
102:1693-1697.
2008
-
Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure)..
102:1524-1529.
2008
-
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry)..
102:1427-1432.
2008
-
Patterns of upstream antiplatelet therapy use before primary percutaneous coronary intervention for acute ST-elevation myocardial infarction (from the CRUSADE National Quality Improvement Initiative)..
102:1335-1340.
2008
-
Profile of chronic and recurrent angina pectoris in a referral population..
102:1301-1306.
2008
-
Relation between aspirin dose, all-cause mortality, and bleeding in patients with recent cerebrovascular or coronary ischemic events (from the BRAVO Trial)..
102:1285-1290.
2008
-
Relation between previous lipid-lowering therapy and infarct size (creatine kinase-MB level) in patients presenting with acute myocardial infarction..
102:1119-1124.
2008
-
Effect of statin treatment before percutaneous coronary intervention on periprocedural myonecrosis: A meta-analysis of published studies.
100:770-776.
2007
-
Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).
2017
-
Comparison of Risk of Atrial Fibrillation in Black Versus White Patients After Coronary Artery Bypass Grafting.
2016